Unknown Manufacturer
Arzoxifene is a selective estrogen receptor modulator (SERM) which antagonizes estrogen in mammary and uterine tissue, but acts as an estrogen receptor agonist in bone tissue. Arzoxifene reduces bone loss and risk of osteoperosis and decreases serum cholesterol.
Investigated for use/treatment in breast cancer, osteoporosis, and endometrial cancer.
One entry per invention. Patent families filed in the US, EP, WO and CN offices.
